Sequenom Gets USPTO Notification of Withdrawn Patent Issuance | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom said Friday evening that it has received notification from the US Patent and Trademark Office that a patent that was scheduled to issue next week has been withdrawn.

The USPTO said that it has withdrawn the issuance of US Patent No. 8,340,916 due to an anticipated patent interference proceeding between parties with pending patent applications or issued patents covering similar subject matter. Sequenom said that it had previously been notified by the USPTO that the patent would issue on Dec. 25.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.